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Background: The term acute aortic syndrome (AAS) encompasses a range of conditions that have a risk of imminent aortic
rupture and where delays in treatment result in increased mortality. Endovascular treatment offers an attractive
alternative to open surgery but little is known about the durability of the repair and the factors that predict mortality.
Methods: Prospective data were collected for a cohort of 110 consecutive patients with endovascular treatment for AAS.
Patient and procedural characteristics were related to short- and midterm outcome using multivariate logistic regression
analysis.
Results: There were 75 men and 35 women with a median age of 68 (range 57-76) years. The pathologies treated were
acute dissection (35), symptomatic aneurysm (32), infected aneurysm (18), transection (12), chronic dissection (9),
penetrating ulcer (3), and intramural hematoma (1). Thirty-day mortality was 12.7% and this was associated with
hypotension (odds ratio [OR], 5.25), use of general anesthetic (OR, 5.23), long procedure duration (OR, 2.03), and
increasing age (OR, 1.07). The causes of death were aortic rupture (4), myocardial infarction (4), stroke (3), and
multisystem organ failure (3). The stroke and paraplegia rates were 7.3% and 6.4%, respectively. The 1-year survival was
81% and the 5-year survival 63%. Secondary procedures were required in 13 (11.8%) patients. Factors associated with
death at 1 year were presence of an aortic fistula (OR, 9.78), perioperative stroke (OR, 5.87), and use of general anesthetic
(OR, 3.76); and at 5 years were aortic fistula (OR, 12.31) and increasing age (OR, 1.06).
Conclusions: Acute aortic syndrome carries significant early and late mortality. Emergency endovascular repair offers a
minimally invasive treatment option associated with acceptable short and midterm results. Continued surveillance is
important as secondary procedures and aortic-related deaths continue to occur throughout the follow-up period. (J Vasc
Surg 2011;54:1580-7.)
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aThe concept of grouping a range of clinical conditions
which share a common life-threatening risk into a single
syndrome came from cardiology, where the term acute
coronary syndrome (ACS) allowed a number of different
clinical presentations of threatened coronary artery occlu-
sion to be considered together, to promote early identifi-
cation and treatment and to improve survival.1-3
The concept of an acute aortic syndrome (AAS) to
encompass those conditions where there is risk of imminent
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1580ortic rupture will allow early identification of patients with
hest pain due to an aortic cause and expedite early imple-
entation of definitive treatment.4,5 Aneurysm, dissection,
ransection, penetrating ulcer, and intramural hematoma
an be grouped together, not because they share the same
athology, but because in the acute setting these aortic
onditions require early identification, transfer to an appro-
riate care facility, rapid institution of medical therapy and
rgent aortic repair with high quality anesthesia, and a
ardiovascular intensive care unit for postprocedure care.6,7
he reason for grouping these conditions into one entity is
o that specific algorithms can be developed in centers
pecializing in aortic intervention with the aim of improv-
ng outcome.8-10
Traditional management of AAS includes open surgical
eplacement of the thoracic aorta and is associated with a
igh perioperative mortality and morbidity.11,12 Endovas-
ular repair of aortic pathology is increasingly being used as
n alternative to open surgery.13-15 The published litera-
ure contains few articles on the endovascular treatment of
atients presenting with acute conditions of the thoracic
orta. We report the midterm follow-up of our experience
f the endovascular management of AAS and investigate
actors that may predict mortality.
ETHODS
The cohort consisted of 110 consecutive patients with
cute thoracic aortic pathology (pathology affecting the
ortic arch and/or descending thoracic aorta) who under-
ent endovascular treatment at a single university teaching
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Volume 54, Number 6 Clough et al 1581hospital between August 1997 and September 2009. A
team of five vascular surgeons and five interventional radi-
ologists provided a 24-hour emergency service.
The study was designed as a retrospective analysis of a
prospectively maintained database, case notes, and imaging
studies. Patient and procedural characteristics were collated
on a standardized pro forma.
Preoperative imaging. All patients underwent bolus-
tracked computed tomography (CT) angiography. Images
were interpreted by both experienced radiologists and sur-
geons to determine suitability for endovascular repair. Du-
plex sonography was used to assess the ascending aorta to
exclude type A dissection and to examine the status of the
carotid and vertebral arteries if deliberate occlusion of the
arch vessels was planned. Magnetic resonance imaging was
not used due to its lack of availability in the emergency
setting.
Initial medical treatment. Patients presenting with
aortic dissection, penetrating ulcer, and intramural hema-
toma were treated initially with hypotensive medication
and analgesia on a high dependency, intensive care, or a
coronary care unit. Blood pressure was titrated to ensure
adequateurineoutput. Initial treatmentwaswith-blockers and
-blockers then angiotensin converting enzyme (ACE)-
inhibitors, angiotensin-2 receptor blockers, calcium chan-
nel blockers, and diuretics. However, patients presenting
with circulatory shock were taken immediately to the en-
dovascular suite after a diagnostic CT scan.
Operative technique. Patients who were conscious
gave written consent. All operative procedures were per-
formed in a hybrid operating theater with fluoroscopic and
angiographic equipment available. Vascular access was
achieved via femoral arteriotomy or prosthetic conduit. A
catheter was inserted in the contralateral groin so that
continuous angiography could be performed during device
deployment. The majority of procedures were performed
under loco-regional anesthesia without routine preopera-
tive placement of a cerebrospinal fluid (CSF) drain. Pro-
phylactic spinal drain insertion was considered if the proce-
dure was performed under general anesthetic; there was
long segment coverage (the descending thoracic aorta from
proximal to the left subclavian to the coeliac axis), planned
occlusion of the left subclavian artery, extensive disease
(proximal to the left subclavian to the coeliac axis with
involvement of infra-renal aorta and/or internal iliacs),
planned occlusion of the internal iliac arteries, or previous
infra-renal aortic repair.
Adjuvant procedures. The innominate and left com-
mon carotid arteries were always revascularized if coverage
of the origin was planned. The left subclavian artery was
assessed in each patient taking into account the status of the
vertebral arteries, the length of aorta to be covered, the
presence of a previous infra-renal repair or aneurysm, and
the status of the internal iliac arteries. Revascularization of
arch vessels was performed immediately before endovascu-
lar repair under the same anesthetic.
Postoperative follow-up. CT angiography was per-
formed at 3 months, and the patient was reviewed in the olinic at 4months. CT angiography and clinical reviewwere
erformed annually thereafter. Data on follow-up were
btained from hospital electronic records and community
ospitals and community care practitioners.
Statistical analysis. SPSS Statistics 17.0 software
SPSS, Inc, Chicago Ill) was used for statistical analysis.
uantitative variables were expressed as median and inter-
uartile range (IQR). Instability was defined as systolic
lood pressure 90 mm Hg. Renal disease was defined as
lomerular filtration rate (GFR)90 mL/min/1.73m2 or
serum creatinine 120 mmol/L. The relationship be-
ween death at 30 days, 1 year, and 5 years, and patient and
rocedural characteristics was compared, and correspond-
ng odds ratios were calculated using univariate logistic
egression analysis. Variables with a P value .2 were
ntered into a multivariate logistic regression model using
orced entry analysis. To enable evaluation of all cases,
issing values were replaced with mean values for the
ariable. No other variables were imputed. A P value of
.05 was considered significant. A Kaplan-Meier survival
lot was produced to show the overall survival of the
ohort.
ESULTS
Patients and operating characteristics. The pathol-
gy, demographics, and procedural details are shown in
able I. The male: female ratio was 75:35, and the median
ge was 68 years (IQR, 57-76). Complicated acute type B
issection was the most common pathology with 19 pa-
ients having a leaking aorta, 11 with end organ ischemia,
nd five with continuing pain. Aortic fistulae included
orto-bronchial, aorto-enteric, and aorto-cutaneous cases.
Thirty-five percent of patients (38/110) had evidence
able I. Patient demographics and procedure details
ariable
ge
(median [IQR]) 68 (57-76)
ender
(male:female) 75:35
ortic pathology
Acute dissection 35
Symptomatic aneurysm 32
Infected aneurysm 18
Transection 12
Chronic dissection 9
Penetrating ulcer 3
Intramural hematoma 1
evice type
Gore TAG 66
Gore Excluder 15
Cook TX2 7
Medtronic Talent 9
Medtronic AneuRx 4
Medtronic Valiant 1
Endofit 6
Gore cTAG 2
QR, Interquartile range.f aortic rupture on preoperative imaging, 26.4% (29/110)
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December 20111582 Clough et alwere hemodynamically unstable, and 23.6% (26/110) had
hemothorax.
Endovascular repair was performed within 24 hours of
presentation to the tertiary care center in 85.5% of patients
(94/110). The technical success rate was 98.2% (108/
110). The two failures were due to inability to seal the
proximal landing zone in patients with symptomatic aneu-
rysm and a tortuous aorta.
The proximal landing zone was Ishimaru zone 0 in one
patient, zone 1 in nine patients, and zone 2 in 54 patients.
Adjuvant procedures were performed in 16 patients (Table
II). Eleven patients had debranching procedures of the
aortic arch to provide an adequate proximal landing zone.
One patient required an aortic conduit for access as the
length of the introducer sheath was designed for use in the
infra-renal aorta. Procedures related to complications were
performed in eight patients (Table II). The external iliac
artery was inadvertently ruptured in two patients and
treated with oversew and femoro-femoral cross-over graft-
ing. Five patients required patch angioplasty of the com-
mon femoral artery for arterial damage caused by the intro-
ducer sheath. The median procedure duration was 90
(IQR, 66-120) minutes and median blood loss was 200
(IQR, 150-400) mL.
Early outcomes. The overall in-hospital mortality was
12.7% (14/110) (Table III). Deaths classified according to
pathology were acute dissection 2/35 (mortality 5.7%),
symptomatic aneurysm 6/32 (18.8%), mycotic aneurysm
3/18 (16.7%), transection 1/12 (8.4%), chronic dissection
1/9 (11.1%), and intramural hematoma 1/1 (100%).
The median time interval between endovascular inter-
vention and 30-day death was 7 days (IQR, 3-20). Four
deaths were related to aortic rupture; one in a patient with
a mycotic aortic aneurysm, one in a patient with an athero-
sclerotic aneurysm where it was not possible to secure a
proximal seal, and two in patients with aortic dissection. In
the latter two cases, the procedures were uncomplicated
but on the third postoperative day the patients died of
rupture of the infra-renal aorta, confirmed at post-mortem
Table II. Adjuvant procedures
Adjuvant procedure
Debranching
Innominate 1
Carotid-carotid 9
Carotid-subclavian 1
Conduit
Iliac 4
Aortic 1
Procedures related to operative complications
Iliac artery injury
Femoro-femoral cross-over 2
Femoral artery injury
Patch angioplasty 5
Other
Left subclavian artery stent 1examination. Three patients died with a stroke and four ratients died following myocardial infarction (one of these
resented with acute dissection). One case of myocardial
nfarction was secondary to deliberate coverage of the
rigin of the left subclavian artery in a patient with aortic
upture, without knowledge that this gave rise to a left
nternal mammary coronary bypass graft. A left subclavian
rtery chimney stent was deployed to re-establish antegrade
ow via a brachial artery puncture.
Overall 15 patients suffered neurological complications
Table III). Eight patients (7.3%) had a stroke (3 died), 6
elated to the anterior circulation and 2 related to the
osterior circulation. Of the patients with anterior circula-
ion stroke, two had atheroma as their primary aortic pa-
hology; of those with a posterior circulation stroke, the
tent graft covered the origin of the left subclavian artery in
oth cases without revascularization.
Seven patients developed paraplegia (6.4%); the proce-
ures had been performed under loco-regional anesthesia
nd therefore the symptoms of spinal cord ischemia were
etected early in their onset. Insertion of a cerebrospinal
uid drain fully reversed the neurological deficit in four
atients.
Secondary procedures. Thirteen patients (11.8%) re-
uired secondary procedures (Table IV), the majority for
anagement of type I endoleak: 3 patients required con-
ersion to open repair; 1 for infolding of the device, 1 for
roximal extension of the aortic dissection, and 1 early in
he series when a large enough device to provide an ade-
uate seal was not commercially available; 4 patients re-
uired extension cuffs, 1 proximal, 2 distal, and 1 patient
able III. In-hospital events
vent
troke
Anterior circulation 6
Posterior circulation 2
araplegia
Reversed with CSF drain 4
Permanent 3
eath
Aortic rupture 4
Myocardial infarction 4
Stroke 3
Multisystem organ failure 3
SF, Cerebrospinal fluid.
able IV. Secondary procedures
ndication Procedure
ndoleak (type I) Explant 3
Proximal extension cuff 1
Distal extension cuff 2
Proximal and distal extension cuff 1
Aortic banding 2
nfection Further stent graft 3
araplegia Cerebrospinal fluid drain 1equired both; 2 patients required open aortic banding due
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Volume 54, Number 6 Clough et al 1583to the proximity of the landing zone to the coeliac artery
and left common carotid arteries, respectively. Three pa-
tients who presented with evidence of aortic infection
suffered recurrent infection and required further stent graft
placement. One patient suffered a myocardial infarction
resulting in systemic hypotension 6 weeks following the
procedure and presented with paraplegia that completely
resolved with cerebrospinal fluid drainage.
Follow-up outcomes. The median follow-up of pa-
tients who were alive at 30 days was 36 months (IQR,
11.8-62.9). There were 22 late deaths that occurred from
month 2 to 132 (Table V). The majority of patients re-
turned to their local area for follow-up and therefore the
cause of death was known in only 50% of cases. Seven
(31.8%) of the late deaths were aortic related, and five
occurred in patients who had initially presented with an
infected aneurysm. Kaplan-Meier analysis demonstrated
a 1-year survival of 81% and the 5-year survival was 63%
(Fig 1).
Predictors of mortality. The results of univariate lo-
gistic regression analysis are shown in Table VI. Significant
independent predictors of death at 30 days, 1 year, and 5
years demonstrated using multivariate logistic regression
analysis are shown below.
(1) 30 days: hypotension (odds ratio [OR], 5.25; 95%
confidence interval [CI], 1.20-22.95; P  .027), use of
general anesthetic (OR, 5.23; 95% CI, 1.34-20.49; P 
.017), long procedure duration (OR, 2.03; 95% CI, 1.05-
3.91; P  .035), and increasing age (OR, 1.07; 95% CI,
Table V. Five out of seven (71%) of the late deaths that
were aortic related occurred in patients who presented
with mycotic pathology
Patient
Presenting
pathology
Cause of late death
Months post
primary
operation
Aortic
related Other
1 Mycotic Yes 2
2 Aneurysm Pneumonia 2
3 Mycotic Yes 2
4 Mycotic Yes 5
5 Acute dissection Unknown 10
6 Aneurysm Pneumonia 13
7 Aneurysm Stroke 17
8 Aneurysm Unknown 20
9 Aneurysm Unknown 20
10 Aneurysm Yes 35
11 Acute dissection Unknown 36
12 Acute dissection Unknown 38
13 Aneurysm Yes 39
14 Aneurysm Unknown 52
15 Aneurysm Lung cancer 52
16 Acute dissection Unknown 55
17 Acute dissection Unknown 62
18 Mycotic Yes 62
19 Mycotic Yes 64
20 Chronic dissection Unknown 83
21 Acute dissection Unknown 111
22 Transection Unknown 1321.01-1.13; P  .026). u(2) 1 year: presence of an aortic fistula (OR, 9.78; 95%
I, 1.51-63.50; P .017), perioperative stroke (OR, 5.87;
5% CI, 1.05-32.92; P  .044), and use of general anes-
hetic (OR, 3.76; 95% CI, 1.13-12.49; P  .031).
(3) 5 years: presence of an aortic fistula (OR, 12.31;
5% CI, 1.69-89.47; P  .013) and increasing age (OR,
.06; 95% CI, 1.01-1.10; P  .021).
ISCUSSION
Endovascular repair is an attractive alternative to con-
entional open surgery for treatment of AAS. There are
urrently no randomized controlled trials comparing endo-
ascular with open surgery for AAS and so the evidence for
fficacy has been derived from large multicenter registries
uch as EUROSTAR, the UK Thoracic Registry, and
RAD.16,17 Single center cohort studies have evaluated
ndividual diseases within AAS and have shown better out-
ome compared to open surgery with regard to ruptured
escending thoracic aneurysm, complicated type B aortic
issection, and aortic transection.18-23
This study has shown that endoluminal repair of pa-
ients presenting with AAS is associated with a 30-day
ortality of 12.7%, and this compares favorably with the
esults from open surgery wheremortality is in the region of
5% to 45%.11,12,24-26 The benefit of endovascular repair is
aintained at midterm follow-up with survival figures of
1% and 63% at 1 and 5 years, respectively. Multivariate
ogistic regression analysis of patient and procedural factors
elated to the repair has demonstrated that hypotension,
eneral anesthesia, a long procedure duration, and old age
re independent predictors of 30-day mortality. Hypoten-
ion and old age are known to be predictors of perioperative
ortality in patients undergoing aortic intervention, and
Fig 1. Kaplan-Meier survival analysis.nstable patients are more likely to undergo general anes-
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loco-regional block.27 A long procedure time indicates a
more complex repair, associated with a higher rate of
reintervention and further hospital admissions affecting
long-term outcome. At 1 year, perioperative stroke in-
creases the chance of death by almost sixfold. However, the
presence of an aortic fistula demonstrated the greatest
strength of association of all the variables analyzed at both
1 and 5 years. Endovascular treatment of infected aortic
pathology has previously been suggested as a temporizing
measure, and this series suggests that in the presence of an
aortic fistula, endovascular treatment should form a bridge
to definitive open repair.28-30 However, in this series most
of the patients who presented with infected aneurysms and
fistulae were deemed unfit for surgery. Those who were fit
declined open surgery when it was offered.
The risk of neurologic complications may be increased
in the emergency setting because the hypovolemic state of
the patient may contribute to cerebral and spinal cord
hypoperfusion. In this series, the rate of stroke and perma-
nent paraplegia were 7.3% and 2.7%, respectively, both of
which compare favorably with conventional surgical treat-
ment.12,25 The stroke rate in particular is encouraging as
58% of patients required placement of the stent graft in the
aortic arch to achieve an adequate proximal seal. Previous
series have documented an association between aneurysmal
pathology of the arch and embolization during catheter
and wire manipulation resulting in anterior circulation
Table VI. Predictors of death at 30 days, 1 year, and 5 ye
Variable entered into
regression model
Result
30 days
Sig OR 95% CI
Age (years) 0.057 1.048 0.999-1.100 0
Female sex 0.363 1.700 0.542-5.328 0
Coronary artery disease 0.784 1.212 0.306-4.795 0
Lung disease 0.475 1.538 0.472-5.015 0
Renal disease 0.368 2.167 0.403-11.658 0
Hypotension 0.130 2.446 0.769-7.778 0
Rupture 0.453 1.547 0.495-4.835 0
Aortic fistula 0.752 1.431 0.155-13.227 0
Leg ischemia 0.647 0.608 0.072-5.112 0
General anesthetic 0.034a 3.545 1.100-11.432 0
Operation duration
(hours)
0.017a 1.784 1.108-2.873 0
Intraoperative blood
loss 500 mL 0.271 2.050 0.572-7.353 0
LSCA coverage 0.886 1.085 0.354-3.326 0
LCCA coverage 0.374 1.778 0.501-6.313 0
Perioperative stroke 0.042a 5.073 1.064-24.184 0
Spinal drain insertion
for paraplegia 0.646 1.467 0.286-7.513 0
Endoleak 0.349 0.367 0.045-2.993 0
Reintervention b b b 0
CI, Confidence interval; OR, odds ratio.
aP  .05.
bNo deaths in this group.stroke.31 However, this is not substantiated in this study in thich only two of the six patients with anterior circulation
troke had atherosclerotic aneurysms as their primary pa-
hology. Two patients had a posterior circulation infarction
ith intentional occlusion of the left subclavian artery
ithout revascularization. The Society for Vascular Surgery
nd the majority of reviews and cohort studies now support
evascularization prior to planned coverage.32-35 However,
n the acute setting of an unstable patient with aortic
upture this is not always possible.
The study extends over 12 years, and the follow-up
rotocol has developed over that time in accordance with
hanges in imaging technology and published clinical data.
nitially the patients underwent CT imaging prior to dis-
harge and at 3, 6, and 12 months, and then annually
hereafter. Due to concerns over radiation levels, this was
educed to a discharge CT scan if there were any concerns
egarding the repair, otherwise a CT scan at 3 months and
hen annually thereafter. Tertiary referrals had their scans
erformed locally by the referring physician and these were
hen sent for discussion at our multidisciplinary meeting.
A reason for concern about the endovascular manage-
ent of AAS is the occurrence of graft-related complica-
ions during follow-up. Early endovascular devices were
oo rigid to track and conform to the aortic arch and eight
ercent of the patients in this series had type I endoleak,
alf of which required conversion to open repair. The
ntroduction of compliant devices and the development of
isease specific endografts may reduce this complication in
sing univariate logistic regression analysis
nivariate logistic regression analysis
1 year 5 years
OR 95% CI Sig OR 95% CI
1.207 0.991-1.065 0.012a 1.044 1.010-1.079
1.688 0.613-4.648 0.173 1.821 0.770-4.310
0.781 0.205-2.972 0.007a 3.905 1.451-0.506
0.920 0.301-2.812 0.012a 3.100 1.277-7.525
1.445 0.276-7.566 0.693 1.339 0.313-5.723
1.405 0.479-4.120 0.639 1.248 0.495-3.148
1.167 0.418-3.258 0.509 1.336 0.565-3.158
5.625 1.042-30.373 0.048a 5.852 1.014-33.767
1.750 0.426-7.181 0.077 3.000 0.887-10.149
2.118 0.782-5.740 0.785 0.887 0.375-2.099
2.141 1.256-3.648 0.006a 2.083 1.231-3.525
2.604 0.848-1.998 0.061 2.603 0.955-7.096
1.599 0.589-4.336 0.386 1.444 0.625-3.317
2.221 0.734-6.720 0.042a 2.738 1.037-7.230
5.933 1.337-26.326 0.035a 5.000 1.117-22.377
2.833 0.757-10.60 0.259 2.033 0.593-6.966
0.566 0.119-2.697 0.251 1.856 0.646-5.330
0.342 0.042-2.784 0.475 1.538 0.472-5.015ars u
s of u
Sig
.146
.311
.717
.884
.663
.536
.769
.045a
.437
.140
.005a
.094
.357
.158
.019a
.122
.475
.316he future.
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to aortic infection. Multivariate analysis demonstrated a
strong association between aortic infection and mortality,
many dying early in the series due to multisystem organ
failure. Those that survived the initial period continued to
have ongoing problems with infection and constituted 71%
of late aortic-related deaths. Vigilant surveillance was im-
portant as aortic-related deaths continued to occur during
the follow-up period.
Internationally, the management of aortic disease has
changed during this study and now endovascular therapy is
an established treatment for disease of the thoracic aorta.
Thoracic endovascular treatment was introduced in our
unit in 1997. Prior to this, all thoracic aortic procedures
were performed by open surgical repair. Initially a small
number of patients who had symptomatic aneurysms and
severe comorbidity were referred for endovascular treat-
ment. The results were good, and now endovascular treat-
ment and appropriate blood pressure management is estab-
lished in our center as the first line treatment for all aortic
pathology of the arch and descending thoracic aorta.
Despite the diversity of the pathology within acute
aortic syndrome, these patients are at risk of imminent
aortic rupture and early diagnosis and treatment improves
survival. Acute care pathways introduced for myocardial
infarction and stroke have successfully improved outcome.
A similar algorithm for acute aortic syndrome should facil-
itate rapid initiation of definitive treatment in an appropri-
Fig 2. Aneurysm, dissection, penetrating ulcer, intramu
in the acute setting these aortic conditions all require ear
institution of medical therapy, and urgent aortic repair.ately certified facility (Fig 2). Hospital and surgeon volume aave been used as a surrogate marker for quality and
orrelate with lower mortality and morbidity after vascular
rocedures. The concept of an acute aortic center has
herefore been proposed to streamline treatment thereby
urther improving results in this complex group of patients.
Limitations. The data presented in the manuscript
epresent over 12 years of a single centers’ experience in the
anagement of patients presenting with AAS. The tertiary
ature of the referrals may introduce a bias with case
election, and the expertise of a specialist referral center may
ot be applicable to less experienced centers. The follow-up
f patients from tertiary centers was limited by patient
ompliance. The present study details, to our knowledge,
he largest series to date of endovascular repair of AAS.
owever, a sample size of 110 may be too small to inves-
igate patient and procedural factors that predict mortality
nd result in type II error during interpretation of the
esults. We chose not to correct for multiple testing to
void type II error but accept that this may have resulted in
ype I error. Finally, although our analyses have demon-
trated significant independent predictors of mortality,
hese findings may have been affected by unknown con-
ounders or under-reporting of events.
ONCLUSION
Endovascular repair of acute aortic syndrome provides
viable alternative to conventional open surgery and is
ssociated with encouraging results. However, it is associ-
matoma, and transection are grouped together because
ntification, transfer to an appropriate care facility, rapidral he
ly ideted with a significant number of secondary procedures.
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emphasizes the importance of vigilant clinical and imaging
surveillance.
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